PlushCare research and fine print
PlushCare's current terms identify PlushCare, Inc. as a Delaware platform company and Fabric Labs, Inc. subsidiary. They distinguish those companies from the physician-owned Provider PCs that furnish medical care. The current HIPAA notice lists multiple location-dependent professional entities, so the future treating corporation must be confirmed from the patient's records.
An official acquisition presentation described PlushCare as pioneering virtual primary care since its founding and operating in all 50 states. Current public pages continue to claim nationwide physician licensure. The terms now use 157 West 18th Street, 2nd Floor, New York, New York 10011 for legal contact, while older first-party material described San Francisco as its base, so this draft does not label either city as current headquarters.
The standard member path begins with doctor selection and a scheduled video visit. For weight management, the physician reviews medical history and goals, may order laboratory work, and may schedule a follow-up to review results and decide whether prescribing is appropriate. A booking, payment, BMI threshold, or medication request never guarantees a prescription.
The weight-loss page says a patient with type 2 diabetes, BMI of at least 30, or BMI of at least 27 with one weight-related condition may be a candidate. It says PlushCare does not start weight-loss pharmacotherapy for a new patient with a normal BMI unless outside records document prior obesity, and it excludes patients with symptoms of an active eating disorder from that medication pathway.
Membership costs $149 annually or $19.99 monthly after a 30-day free trial. The annual option equals $12.42 per month, and the unweighted mean of $12.42 and $19.99 is $16.20. The card label rounds to Avg. $16/mo and keeps the exact bill and prepayment terms in the notes.
The membership is a platform and service fee, not an all-in weight-loss program price. Self-pay physician visits cost $129 each. Insured patients pay an estimated responsibility at booking, and the final balance can change after claim processing. Medication, labs, deductibles, coinsurance, and third-party fees are separate.
PlushCare says membership payment is not a prerequisite to receive medical care. Its limited-access support article says a patient can call to schedule without the proprietary online booking, app renewal requests, free in-app messaging, and related member conveniences. The public page does not state a different medical-visit price for that route.
Semaglutide injections consolidate Wegovy for chronic weight management, Ozempic for type 2 diabetes, and any legally patient-specific compounded injection into one ingredient-and-route record. Brand indication, regulatory status, formulation, dose, and coverage remain explicit rather than being treated as interchangeable products.
PlushCare's semaglutide page says compounded semaglutide is available only while branded semaglutide appears on FDA's shortage list. FDA states that semaglutide and tirzepatide do not currently appear on that list and recommends compounded GLP-1 drugs only when a patient's medical needs cannot be met by an approved drug. The conditional compound is therefore context, not a currently comparable offer.
The same semaglutide page lists $149 for the 0.25 mg compounded dose and $299 for higher doses but makes those prices contingent on shortage availability. Its Wegovy page also retains an expired $199 introductory offer and a $399 follow-on amount, while current NovoCare terms use different dose-specific prices. None of those figures enters the therapy-card comparison.
Injected tirzepatide consolidates Zepbound for weight management and Mounjaro for type 2 diabetes. PlushCare's Zepbound page publishes cash figures for manufacturer fulfillment and correctly makes prescribing, dose, and coverage conditional, but the page omits some current dose and regular-price terms. Manufacturer eligibility and refill timing therefore require confirmation outside PlushCare.
Injected liraglutide consolidates Saxenda for weight management and Victoza for type 2 diabetes. Oral semaglutide remains a separate route represented by Rybelsus on PlushCare's current catalog. A clinician must decide whether any diabetes-labeled product is appropriate for the patient's actual diagnosis rather than using a brand merely for weight loss.
Non-GLP-1 choices are normalized to their ingredients: naltrexone plus bupropion for Contrave, oral orlistat for Xenical or generic orlistat, oral topiramate, and oral bupropion for Wellbutrin. Topiramate and bupropion may involve off-label weight-management use, which requires individualized consent and does not convert them into new branded therapies.
PlushCare says weight-management labs are often required. Its semaglutide and Zepbound pages describe an obesity panel with CBC, CMP, lipids, A1C, TSH, and insulin. The actual tests, laboratory, insurance coverage, cash price, repeat interval, and whether outside results are accepted remain clinician and patient specific.
PlushCare generally sends prescriptions to a local pharmacy chosen by the patient, and some manufacturer or mail-order routes may be available. It is not an online pharmacy, does not guarantee a drug will be prescribed, and says it is not responsible for pharmacy acts or omissions. There is no universal provider-controlled shipping fee, cold-chain standard, replacement promise, or delivery time.
The refund policy covers an appointment if PlushCare cannot treat or assess the patient, connectivity prevents the consultation, the doctor is more than ten minutes late, or a licensing problem blocks lawful care. Once a physician performs any assessment, gives advice, orders labs, or refers the patient elsewhere, the appointment can be nonrefundable even without a prescription. Prescription sales are final.
Membership cancellation is available through the profile and must be completed at least one calendar day before renewal. The terms say a canceled membership stays active through the current term and does not renew. Public pages do not promise a prorated refund for a routine member cancellation.
Members receive unlimited in-app care-team messaging, and PlushCare describes 24/7 care-team access. Support is also available at info@plushcare.com and (800) 221-5140. Messages are not a substitute for emergency care, and the public pages do not promise one response time for every clinical question.
PlushCare treats information supplied as a logged-in patient to a Provider PC as PHI governed by HIPAA. Its separate public-site privacy policy covers identifiers, device activity, approximate location, pre-login quiz or questionnaire health data, analytics cookies, and sharing that may qualify as sale or sharing under state privacy law.
Katalys program 344 remains pending. The commercial record shows a $60 approved-sale payout and $1.12 network-benchmark EPC, but no tracking URL, cookie, attribution rule, reversal policy, paid-media permission, or affiliate-approved customer offer. Affiliate economics affected research order only, not the verdict or score.
- This review covers PlushCare's weight-management pathway, not its unrelated mental-health or urgent-care services.
- Eight cards use active ingredients and routes instead of multiplying manufacturer brands.
- The annual and monthly membership equivalents average $16.20 per month before visits, labs, and prescriptions.
- Self-pay doctor visits cost $129 each; a recurring follow-up cadence is not publicly fixed.
- Often-required obesity labs and prior authorization can add time and cost before medication access.
- The Wegovy page retains an expired NovoCare price, while current manufacturer terms differ.
- Compounded semaglutide is described as shortage-contingent, while FDA currently lists neither semaglutide nor tirzepatide as in shortage.
- Prescriptions go to a chosen pharmacy, so product cost, stock, pickup, shipping, and returns follow third-party terms.
- A clinician assessment can be nonrefundable even if the patient does not receive the requested medication.
- The Katalys application remains pending, so the CTA is untracked and shows no customer promotion.